Viewing nowCombinationVersace Tablets 40/5mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.

MFDS item code 201606770 · Approved 2016.11.25 · Insurance code 644003800
Treatment of essential hypertension not controlled with monotherapy
Patients with essential hypertension can effectively lower their blood pressure using this medication when blood pressure is not adequately controlled with telmisartan or amlodipine alone. This helps improve blood pressure control and reduce the risk of cardiovascular diseases.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (limited to this medicine 40/5mg and 80/10mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to individuals with allergies to the active ingredient or similar components, biliary obstruction diseases, severe liver disease, serious heart problems, severe hypotension, cardiogenic shock, or unstable heart failure following acute myocardial infarction. Special precautions are required when using this medication in patients with specific heart diseases, liver disease, gastrointestinal diseases, kidney problems, the elderly, etc., and regular monitoring of blood pressure and kidney function is recommended. Various side effects such as dizziness, peripheral edema, headaches, hypotension, heart rhythm abnormalities, and digestive disorders may occur when taking this medication, so if any unusual symptoms arise, consult a doctor or pharmacist immediately. This medication may interact when taken with other antihypertensive medications or specific drugs, so it is essential to inform healthcare professionals of any other medications being taken. Women who are pregnant or breastfeeding should not take this medication, and if pregnancy is confirmed, the medication should be discontinued immediately and healthcare professionals should be consulted. This medication is not recommended for children or adolescents under 18 years of age, and in the elderly, dosage should be adjusted and used cautiously. In cases of overdose, symptoms such as hypotension, heart rhythm abnormalities, dizziness, and acute renal failure may occur, and immediate medical treatment should be sought. This medication should be stored out of reach of children and taken immediately after opening the packaging.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in an airtight container that blocks light and kept at a safe temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the integrity of the medication's components and keep its effectiveness.
White to pale yellow and light blue, double convex oval tablets
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.